Badgley Phelps Wealth Managers, LLC Amgen Inc Transaction History

Badgley Phelps Wealth Managers, LLC

$4 Billion
Q2 2024

A detailed history of Badgley Phelps Wealth Managers, LLC transactions in Amgen Inc stock. As of the latest transaction made, Badgley Phelps Wealth Managers, LLC holds 46,136 shares of AMGN stock, worth $14.9 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

46,136

Previous 46,132 0.01%

Holding current value

$14.9 Million

Previous $13.1 Million 9.9%

% of portfolio

0.36%

Previous 0.35%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $1,051 - $1,277	4 Added 0.01%	46,136 $14.4 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $215,096 - $259,648	800 Added 1.76%	46,132 $13.1 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $1.72 Million - $1.94 Million	6,717 Added 17.39%	45,332 $13.1 Million
Q3 2023 Nov 02, 2023	BUY	$218.65 - $271.46 $37,389 - $46,419	171 Added 0.44%	38,615 $10.4 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $24,426 - $28,884	114 Added 0.3%	38,444 $8.54 Million
Q1 2023 Apr 28, 2023	BUY	$225.79 - $275.2 $58,028 - $70,726	257 Added 0.68%	38,330 $9.27 Million
Q4 2022 Jan 27, 2023	BUY	$229.03 - $291.01 $20,154 - $25,608	88 Added 0.23%	38,073 $0
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $192,137 - $216,696	856 Added 2.31%	37,985 $8.56 Million
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $33,452 - $37,227	-145 Reduced 0.39%	37,129 $9.03 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $117,090 - $129,532	-534 Reduced 1.41%	37,274 $9.01 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $77,563 - $88,764	-390 Reduced 1.02%	37,808 $8.51 Million
Q3 2021 Nov 29, 2021	BUY	$212.27 - $248.7 $8.11 Million - $9.5 Million	38,198 New	38,198 $8.12 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Badgley Phelps Wealth Managers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Badgley Phelps Wealth Managers, LLC with notifications on news.

Account

Badgley Phelps Wealth Managers, LLC Amgen Inc Transaction History